CI vs HUM

Cigna and Humana, both Healthcare

Cigna is the larger company at $74B against $43B. On trailing earnings CI is the cheaper of the two at a P/E of 11.6 against 41.7, a gap that is only a bargain if the two are growing at similar rates. Over the past year HUM returned +54% against +6.3% for CI.

Cigna and Humanacompared on valuation, return and Ryufin’s Smart Score
Figure	CI	HUM
Last close	$281	$391
Market cap	$74B	$43B
Trailing P/Elower is cheaper for the same earnings, not automatically better	11.6	41.7
Dividend yield	2.2%	0.9%
1-year return	+6.3%	+54%
5-year return	+34%	-3.7%
Ryufin Smart Scoresector-relative, 1–10	6/10	6/10

Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.

Cigna

Revenue of $72B in Q2 2026, net income $1.9B. Its largest reported line is Network Pharmacy, 49% of the disclosed total.

CI overview revenue and segments valuation

Humana

Revenue of $40B in Q1 2026, net income $1.2B. Its largest reported line is Center Well, 85% of the disclosed total.

HUM overview revenue and segments valuation

Open these two in the interactive comparison to add more names, change the period or read the correlation.